Rhythm Pharmaceuticals

RYTMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.764 B

$98.24 -1.04%

Close of 23 Sept 2026

Revenue

$189.8M

#2302 by revenue

Earnings

-$196.5K

Loss-making

Shares outstanding

68,852,082

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →

#43AlkermesALKS$7.07B
#44Belite BioBLTE$6.79B
#45Rhythm PharmaceuticalsRYTM$6.76B
#46Amneal PharmaceuticalsAMRX$6.73B
#47LiquidiaLQDA$6.04B

What if Rhythm Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $29.8T

$433,493.46

Per share 4,413× higher

Bitcoin $1.69T

$24,605.22

Per share 250× higher

Nvidia $5.43T

$78,934.30

Per share 803× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Rhythm Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.